Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04249011 · ClinicalTrials.gov registry record
WatchPAT Compared to PSG at 8500'
A clinical trial of Sleep Disorder; Breathing-Related, sponsored by Itamar-Medical, Israel.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT04249011: Completed study of Sleep Disorder; Breathing-Related, sponsored by Itamar-Medical, Israel.
NCT04249011 is a study of Sleep Disorder; Breathing-Related that has completed, run by Itamar-Medical, Israel. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04249011, a study of Sleep Disorder; Breathing-Related, has completed, sponsored by Itamar-Medical, Israel.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects who consent to participate in the research will undergo a simultaneous recording of inlab PSG and WatchPAT200 for comparing the WatchPAT data to PSG at an altitude of 8500'.
Conditions Studied
Study Locations (1)
Colorado
- Mountain Sleep Diagnostics - Woodland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-05-02 |
| Est. Completion | 2019-12-10 |
What the finished NCT04249011 record still lists
NCT04249011 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 1 condition, with Sleep Disorder; Breathing-Related appearing as the primary indexed condition, and to 0 interventions.
NCT04249011 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04249011 about?
NCT04249011 is a clinical study titled "WatchPAT Compared to PSG at 8500'". Subjects who consent to participate in the research will undergo a simultaneous recording of inlab PSG and WatchPAT200 for comparing the WatchPAT data to PSG at an altitude of 8500'.
What is the current status of trial NCT04249011?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2018-05-02. Estimated completion is 2019-12-10.
What conditions does trial NCT04249011 study?
This clinical trial studies the following conditions: Sleep Disorder; Breathing-Related.
Who is sponsoring clinical trial NCT04249011?
This trial is sponsored by Itamar-Medical, Israel, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04249011 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder; Breathing-Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI